Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imprime PGG with cetuximab and chemotherapy in advanced NSCLC
NCT00874848Phase 2Completed
- Sponsor
- HiberCell
- Start
- Aug 2009
- Primary completion
- Nov 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of odetiglucan in non-small cell lung cancer (NSCLC), sponsored by HiberCell. Started Aug 2009; status: completed.
02
Drugs
odetiglucan
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00874848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874848.